Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 238

1.

Dermoscopy in the Evaluation of Nail Disorders.

Alessandrini A, Starace M, Piraccini BM.

Skin Appendage Disord. 2017 May;3(2):70-82. doi: 10.1159/000458728. Epub 2017 Mar 8. Review.

PMID:
28560217
2.

Dermoscopy of Subungual Exostosis: A Retrospective Study of 10 Patients.

Piccolo V, Argenziano G, Alessandrini AM, Russo T, Starace M, Piraccini BM.

Dermatology. 2017 May 9. doi: 10.1159/000471800. [Epub ahead of print]

PMID:
28482347
3.

Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL.

Madeddu G, Rusconi S, Cozzi-Lepri A, Di Giambenedetto S, Bonora S, Carbone A, De Luca A, Gianotti N, Di Biagio A, Antinori A; Icona Foundation Study Group.

Infection. 2017 May 5. doi: 10.1007/s15010-017-1018-z. [Epub ahead of print]

PMID:
28477212
4.

Oxytetracycline induces DNA damage and epigenetic changes: a possible risk for human and animal health?

Gallo A, Landi R, Rubino V, Di Cerbo A, Giovazzino A, Palatucci AT, Centenaro S, Guidetti G, Canello S, Cortese L, Ruggiero G, Alessandrini A, Terrazzano G.

PeerJ. 2017 Apr 27;5:e3236. doi: 10.7717/peerj.3236. eCollection 2017.

5.

Erythropoietin Receptor-Mediated Molecular Crosstalk Promotes T Cell Immunoregulation and Transplant Survival.

Purroy C, Fairchild RL, Tanaka T, Baldwin WM 3rd, Manrique J, Madsen JC, Colvin RB, Alessandrini A, Blazar BR, Fribourg M, Donadei C, Maggiore U, Heeger PS, Cravedi P.

J Am Soc Nephrol. 2017 Mar 16. pii: ASN.2016101100. doi: 10.1681/ASN.2016101100. [Epub ahead of print]

PMID:
28302753
6.

Erosive pustular dermatosis of the scalp: Clinical, trichoscopic, and histopathologic features of 20 cases.

Starace M, Loi C, Bruni F, Alessandrini A, Misciali C, Patrizi A, Piraccini BM.

J Am Acad Dermatol. 2017 Jun;76(6):1109-1114.e2. doi: 10.1016/j.jaad.2016.12.016. Epub 2017 Feb 14.

PMID:
28214042
7.

FOXP3-Positive Regulatory T Cells and Kidney Allograft Tolerance.

Alessandrini A, Turka LA.

Am J Kidney Dis. 2017 May;69(5):667-674. doi: 10.1053/j.ajkd.2016.10.027. Epub 2016 Dec 31. Review.

PMID:
28049555
8.

Seasonal characterisation of maritime traffic and the relationship with cetacean presence in the Western Mediterranean Sea.

Campana I, Angeletti D, Crosti R, Luperini C, Ruvolo A, Alessandrini A, Arcangeli A.

Mar Pollut Bull. 2017 Feb 15;115(1-2):282-291. doi: 10.1016/j.marpolbul.2016.12.008. Epub 2016 Dec 18.

PMID:
27993370
9.

Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus.

Puoti M, Lorenzini P, Cozzi-Lepri A, Gori A, Mastroianni C, Rizzardini G, Mazzarello G, Antinori A, d'Arminio Monforte A, Girardi E; Icona Foundation Study Group.

Clin Microbiol Infect. 2017 Apr;23(4):267.e1-267.e4. doi: 10.1016/j.cmi.2016.12.003. Epub 2016 Dec 9.

PMID:
27956268
10.

Direct electrical control of IgG conformation and functional activity at surfaces.

Ghisellini P, Caiazzo M, Alessandrini A, Eggenhöffner R, Vassalli M, Facci P.

Sci Rep. 2016 Nov 24;6:37779. doi: 10.1038/srep37779.

11.

Periungual Pyogenic Granuloma: The Importance of the Medical History.

Alessandrini A, Bruni F, Starace M, Piraccini BM.

Skin Appendage Disord. 2016 May;1(4):175-8. doi: 10.1159/000444302. Epub 2016 Feb 24.

12.

Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART.

Squillace N, Lorenzini P, Lapadula G, Bandera A, Cozzi-Lepri A, Rusconi S, Puoti M, Castagna A, Antinori A, Gori A, d'Arminio Monforte A; Icona Foundation Study Group.

J Antimicrob Chemother. 2016 Sep;71(9):2663-9. doi: 10.1093/jac/dkw185. Epub 2016 Jun 5.

PMID:
27272727
13.

Tinea Incognita following the Use of an Antipsoriatic Gel.

Starace M, Alessandrini A, Piraccini BM.

Skin Appendage Disord. 2016 Feb;1(3):123-5. doi: 10.1159/000441193. Epub 2015 Oct 16.

14.

Discontinuation of Initial Antiretroviral Therapy in Clinical Practice: Moving Toward Individualized Therapy.

Di Biagio A, Cozzi-Lepri A, Prinapori R, Angarano G, Gori A, Quirino T, De Luca A, Costantini A, Mussini C, Rizzardini G, Castagna A, Antinori A, dʼArminio Monforte A; ICONA Foundation Study Group.

J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):263-71. doi: 10.1097/QAI.0000000000000849.

15.

Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study.

Mocroft A, Lundgren JD, Ross M, Fux CA, Reiss P, Moranne O, Morlat P, Monforte Ad, Kirk O, Ryom L; Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) Study.

Lancet HIV. 2016 Jan;3(1):e23-32. doi: 10.1016/S2352-3018(15)00211-8. Epub 2015 Nov 17.

PMID:
26762990
16.

Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus.

Mussini C, Lorenzini P, Puoti M, Lichtner M, Lapadula G, Di Giambenedetto S, Antinori A, Madeddu G, Cozzi-Lepri A, d'Arminio Monforte A, De Luca A; ICONA Foundation Study Group.

PLoS One. 2015 Dec 7;10(12):e0140877. doi: 10.1371/journal.pone.0140877. eCollection 2015.

17.

Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort.

Saracino A, Lorenzini P, Lo Caputo S, Girardi E, Castelli F, Bonfanti P, Rusconi S, Caramello P, Abrescia N, Mussini C, Monno L, d'Arminio Monforte A; ICONA Foundation Study Group.

Clin Microbiol Infect. 2016 Mar;22(3):288.e1-8. doi: 10.1016/j.cmi.2015.10.026. Epub 2015 Nov 10.

18.

Psoriasiform nail lesions in a patient with artificial nails.

Piraccini BM, Alessandrini A, Magnano M, Vincenzi C, Patrizi A.

G Ital Dermatol Venereol. 2015 Dec;150(6):761-2. No abstract available.

PMID:
26513048
19.

Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients.

Sticchi L, Di Biagio A, Sartini M, Rappazzo E, Nicolini LA, Cenderello G, Valle C, Azzola E, Grasso A, De Leo P, Boldrini A, Setti M, Prinapori R, Lorusso C, Bruzzone B, Icardi G; Ligurian HIV Network.

New Microbiol. 2015 Oct;38(4):499-509. Epub 2015 Oct 20.

20.

Evaluation of efficacy and tolerability of four weeks bifonazole treatment after nail ablation with 40% urea in mild to moderate distal subungual onychomycosis.

Piraccini BM, Bruni F, Alessandrini A, Starace M.

G Ital Dermatol Venereol. 2016 Feb;151(1):32-6. Epub 2015 Oct 16.

PMID:
26472342

Supplemental Content

Loading ...
Support Center